Blog

Enrique Grande: Lucky to participate in the Annual Congress of the Spanish Group of Neuroendocrine Tumors

Enrique Grande/LinkedIn

Nov 21, 2024, 21:31

Enrique Grande: Lucky to participate in the Annual Congress of the Spanish Group of Neuroendocrine Tumors

Enrique Grande, Head of Oncology at MD Anderson Cancer Center Madrid, shared a post on LinkedIn:

“Last week I was lucky enough to participate in the Annual Congress of the Spanish Group of Neuroendocrine Tumors (GETNE) in the magical Santiago de Compostela.

I want to thank GETNE and NET Spain from the bottom of my heart for organizing such a special meeting. It was a privilege to share this space with colleagues, friends and patients who, with their stories and their desire, inspire us to continue working.

I take away much more than data and debates:

The certainty that we are surrounded by incredible professionals.
The warmth of a community united by a common goal.
And the hope of a future full of possibilities for the management of these tumors.

Thank you all for your hospitality and for the moments shared, inside and outside the auditorium. Santiago will always be a special place for me.

We move forward, together and stronger than ever.”

More posts featuring Enrique Grande.

Enrique Grande, MD, PhD, MSc, is the Head of Oncology at MD Anderson Cancer Center Madrid, and an Associate Professor at Francisco de Vitoria University. He is also an Adjunct Professor at the GU Medical Oncology Department.

Grande specializes in researching genitourinary and endocrine tumors and actively collaborates in developing the Translational Research and Early Drug Development Unit. He founded the Spanish Group for Research on Orphan and Uncommon Tumors (GETHI) and serves on the Directory Board of the Spanish Task Force Group for NETs (GETNE).

Dr. Grande edits several international journals and has participated in recent neuroendocrine tumor trials that led to the approval of new drugs in this field.